Pulmonary complications in patients with hematological disorders: Pathobiological bases and practical approach

Seminars in Respiratory and Critical Care Medicine

Volumn 26, Issue 5, 2005, Pages 439-444

  Poletti, Venerino ^a   Costabel, Ulrich ^b   Semenzato, Gianpietro ^c  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b RUHRLANDKLINIK   (Germany)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Bronchoscopic procedures; Chemokines; High resolution CT scan; Immunocompromised host; Pentraxins

Indexed keywords

ANTINEOPLASTIC AGENT; TOXIC SUBSTANCE;

BONE MARROW; BRONCHUS MUCOSA; CELL PROLIFERATION; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; ENDOTHELIUM CELL; GENETIC PREDISPOSITION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS PROTEINOSIS; LUNG BLOOD VESSEL; LUNG CAPILLARY; LUNG COMPLICATION; LUNG EDEMA; LUNG GAS EXCHANGE; LUNG INFECTION; LUNG INFILTRATE; LUNG INJURY; LUNG PARENCHYMA; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; MYELOPROLIFERATIVE DISORDER; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SECOND CANCER;

DISEASE SUSCEPTIBILITY; HEMATOLOGIC DISEASES; HUMANS; LUNG DISEASES;

EID: 27644526459     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-922028     Document Type: Review

References (48)

1. Jabot-Lestang L, Maitre B, Cordonnier C. Puomon et maladies hematologique. Encyclopedie Medico-Chir 2003:1-12
2. Poletti V, Trisolini R, Tura S. Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:29-45
3. Poletti V, Salvucci M, Zanchini R, et al. The lung as a target organ in patients with hematologic disorders. Haematologica 2000;85:855-864
4. Worthen GS, Nick JA. Leukocyte accumulation in the lung. In: Fishman's Pulmonary Diseases and Disorders. New York: McGraw-Hill; 1998:325-346
5. Drost EM, Kassabian G, Meiselman HJ, Gelmont D, Fisher TC. Increased rigidity and priming of polymorphonuclear leukocytes in sepsis. Am J Respir Crit Care Med 1999;159:1696-1702
6. Abramson SL, Malech HL, Gallin JI. Neutrophils. In: Crystal RG, West JB. The Lung:Scientific Foundation. New York: Raven; 1991:553-563
7. Hogg JC. Neutrophil traffic. In: Crystal RG, West JB. The Lung: Scientific Foundation. New York: Raven; 1991:565-577
8. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-2498
9. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug induced lung disease. Clin Chest Med 2004;25:25-35
10. Linssen KC, Jacobs JA, Poletti V, van Mook W, Drent M. Reactive type II pneumocytes in bronchoalveolar lavage fluid. Acta Cytol 2004;48:497-504
11. Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994;149:788-794
12. Kaminsky DA, Hurwitz CG, Olmstead JI. Pulmonary leukostasis mimicking pulmonary embolism. Leuk Res 2000;24:175-178
13. Toews GB. Host defences. In: Albert RK, Spiro S, Jett JR, eds. Clinical Respiratory Medicine. Philadelphia: Mosby; 2004:129-141
14. Delclaux, Azoulay E. Inflammatory response to infectious pulmonary injury. Eur Respir J 2003;42(s):10s-14s
15. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782-787
16. Ding K, Shibui A, Wang Y, Takamoto M, Matsuguchi T, Sugane K. Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia. Microbes Infect 2005;7:195-203
17. Garlanda C, Hirsch E, Bozza S, et al. Nonredundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002;420:182-186
18. Riches DWH, Scott Worthen G, Augustin A, Lapadat R, Chan ED. Inflammation in the pathogenesis of interstitial lung diseases. In: Schwarz MI, King TE Jr. Interstitial Lung Disease. Hamilton, BC: Decker; 2003:187-220
19. Agostini C, Chilosi M, Zambello R, Trentin L, Semenzato G. Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J 1993;6:1378-1401
20. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Alloreactive memory T cells are responsible for the persistence of graft-versus-host-disease. J Immunol 2005;174:3051-3058
21. Vakkila J, Thomson AW, Hovi L, Vettenranta K, Saarinen-Pihkala UM. Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft versus host disease. Bone Marrow Transplant 2005;35:501-507
22. McCormack FX, Shannon JM. Role of the alveolar epithelium in the pathogenesis of pulmonary fibrosis. In: Schwarz MI, King TE Jr. Interstitial Lung Disease. Hamilton, BC: Decker; 2003:221-244
23. Tanoue LT. Pulmonary toxicity associated with chemotherapeutic agents. In: Fishman AP, ed. Fishman's Pulmonary Diseases and Disorders. New York: McGraw-Hill; 1998:480-489
24. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration 2004;71:301-326
25. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-1751
26. Hunninghake GW, Monick MM, Geist LJ. Cytomegalovirus infection: regulation of inflammation. Am J Respir Cell Mol Biol 1999;21:150-152
27. Mocarski ES Jr, Courcelle CT. Cytomegaloviruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2001:2673
28. Piovan E, Tosello V, Indraccolo S, et al. Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation. Blood 2005;105:931-939
29. Tobin M. Advances in mechanical ventilation. N Engl J Med 2001;344:1986-1996
30. Eutamene H, Theodorou V, Schmidlin F, et al. LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK. Eur Respir J 2005;25:789-796
31. Hornsey S, Cullen BM, Myers R, Walker HC, Hedges MJ. Radiation injury in mouse lung: dependence on oxygen levels in the inspired gas. Int J Radiat Biol Relat Stud Phys Chem Med 1986;50:471-479
32. Gulbahce HE, Pambuccian SE, Jessurun J, et al. Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosis. Am J Clin Pathol 2004;121:205-210
33. Ewer MS, Martin FJ, Henderson C, et al. Cardiac safety of liposomal anthracyclines. Semin Oncol 2004;31(Suppl 13):161-181
34. Wiedermann HP. Toward an understanding of idiopathic pneumonia syndrome after bone marrow transplantation. Crit Care Med 1999;27:2040-2041
35. Panoskaltsis-Mortari A, Taylor PA, Yaegar TM, et al. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogenic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clin Invest 1997;100:1015-1027
36. Qureshi MA, Girgis RE, Dandapantula HK, Abrams J, Soubani AO. Increased exhaled nitric oxide following autologous peripheral hematopoietic stem-cell transplantation. Chest 2004;125:281-287
37. Hildebrandt GC, Duffner UA, Olkiewicz KM, et al. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 2004;103:2417-2426
38. Patriarca F, Skert C, Sperotto A, et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004;33:751-758
39. Nicholson AG, Poletti V, Semenzato G. Lymphoprolipherative disease. In: Gibson J, Geddes D, Costabel U, Sterk P, Corrin B, eds. Respiratory Medicine. 3rd ed. London: Harcourt Health Sciences; 2003:1694-1707
40. Coy DL, Ormazabal A, Godwin JD, Lalani T. Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation. Radiographics 2005;25:305-317
41. Heussel CP, Kauczor HU, Heussel GU, et al. Pneumonia in febrile neutropenic patients and bone marrow and blood stem cell transplant recipients: use of high resolution computed tomography. J Clin Oncol 1999;17:928-933
42. Poletti V, Chilosi M, Olivieri D. Diagnostic invasive procedures in diffuse infiltrative lung diseases. Respiration 2004;71:107-119
43. Rano A, Agusti C, Jmenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using noninvasive and bronchoscopic procedures. Thorax 2001;56:379-387
44. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001;7:255-261
45. Rano A, Agusti C, Jmenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using noninvasive and bronchoscopic procedures. Thorax 2001;56:379-387
46. Wong PW, Stefance T, Brown K, White DA. Role of fine-needle aspirates of focal lesions in patients with hematologic malignancies. Chest 2002;121:527-532
47. White DA, Wong PW, Downey R. The utility of open lung biopsy in hematologic patients with pulmonary infiltrates. Am J Respir Crit Care Med 2000;161:723-729
48. Zihlif M, Khanchandani G, Ahmed HP, Soubani AO. Surgical lung biopsy in patients with haematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis. Am J Hematol 2005;78:94-99